Estrogen and progesterone receptor status and its Association with clinicopathological characteristics Among breast cancer patients: a five-year retrospective Study from january 2021 to december 2025 at jimma University medical center, southwest ethiopia

Bethelihem tefera; Gebi nemo

dc.contributor.author	Bethelihem tefera
dc.contributor.author	Gebi nemo
dc.date.accessioned	2026-06-10T07:17:18Z
dc.date.available	2026-06-10T07:17:18Z
dc.date.issued	2026-03
dc.identifier.uri	https://repository.ju.edu.et//handle/123456789/10281
dc.description.abstract	Breast cancer is one of the most common cancers worldwide and a leading cause of cancer related morbidity and mortality. Hormone receptor (HR) status, specifically estrogen receptor (ER) and progesterone receptor (PR), plays a crucial role in guiding treatment decisions and predicting prognosis. However, data on HR expression and its association with clinicopathological characteristics in Ethiopia is limited	en_US
dc.language.iso	en	en_US
dc.subject	Breast cancer	en_US
dc.subject	Estrogen receptor	en_US
dc.subject	Progesterone receptor	en_US
dc.subject	Ethiopia	en_US
dc.title	Estrogen and progesterone receptor status and its Association with clinicopathological characteristics Among breast cancer patients: a five-year retrospective Study from january 2021 to december 2025 at jimma University medical center, southwest ethiopia	en_US
dc.type	Thesis	en_US